Cargando…
Erdheim-Chester Disease Successfully Treated with Front-Line Single-Agent Dabrafenib
Patient: Female, 30-year-old Final Diagnosis: Erdheim-Chester disease Symptoms: Abdominal pain • fatigue Medication: — Clinical Procedure: — Specialty: Hematology OBJECTIVE: Rare disease BACKGROUND: Erdheim-Chester disease (ECD) is a clonal disease characterized by histiocytic infiltration of multip...
Autores principales: | Salama, Hind, Alzayed, Mohammed Fahed, Alharbi, Khalid Ghazi, Khattak, Zohra, Omer, Mohamed H., Tahir, Leena, ALhejazi, Ayman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8861977/ https://www.ncbi.nlm.nih.gov/pubmed/35171900 http://dx.doi.org/10.12659/AJCR.935090 |
Ejemplares similares
-
Erdheim-Chester Disease with No Skeletal Bone Involvement and Massive Weight Loss
por: Salama, Hind, et al.
Publicado: (2017) -
Dabrafenib and Trametinib Treatment for Erdheim-Chester Disease With Brain Stem Involvement
por: Al Bayati, Ahmed, et al.
Publicado: (2018) -
Erdheim Chester Disease treated successfully with cladribine
por: Azadeh, Natalya, et al.
Publicado: (2016) -
Erdheim-Chester Disease
por: Yamamoto, Shinya, et al.
Publicado: (2019) -
Highlights of the Management of Adult Histiocytic Disorders: Langerhans Cell Histiocytosis, Erdheim-Chester Disease, Rosai-Dorfman Disease, and Hemophagocytic Lymphohistiocytosis
por: Salama, Hind Abdin, et al.
Publicado: (2021)